Data / Form D filings / Avalyn Pharma Inc.
Avalyn Pharma Inc.: Form D filings
Avalyn Pharma Inc., a biotechnology company in Seattle, WA, filed 7 Form D notices with the SEC between 2012 and 2023. The latest, on October 10, 2023, reports $189.2 million sold of a $189.2 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 701 PIKE STREET, SUITE 1500, Seattle, WA, 98101
- Phone
- (206) 707-0340
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1540171
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 10, 2023 | New notice | $189,182,622 | $189,182,622 | 26 | Sep 22, 2023 | sec.gov | |
| May 8, 2020 | New notice | $35,695,957 | $35,499,998 | $195,959 | 8 | Apr 24, 2020 | sec.gov |
| May 24, 2017 | Amendment | $64,915,611 | $18,207,187 | $46,708,424 | 46 | Mar 13, 2017 | sec.gov |
| Mar 24, 2017 | New notice | $62,878,616 | $16,621,473 | $46,257,143 | 45 | Mar 13, 2017 | sec.gov |
| Aug 12, 2015 | Amendment | $2,179,480 | $2,179,480 | 41 | Oct 23, 2011 | sec.gov | |
| Mar 24, 2015 | Amendment | $2,000,000 | $1,654,480 | $345,520 | 34 | Oct 23, 2011 | sec.gov |
| Nov 16, 2012 | New notice | $1,200,000 | $1,090,000 | $110,000 | 22 | Oct 23, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lyn Baranowski | Executive Officer, Director | |
| Tiba Aynechi | Director | |
| Ketan Patel | Director | |
| Peter Moldt | Director | |
| Niall O'Donnell | Director | |
| Cassandra Gianna Luca | Director | |
| Jonathan Leff | Director | |
| Jill Gianna Carroll | Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Oct 9, 2023 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Avalyn Pharma Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.